TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?
Originalpublikation Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, TICO Investigators (2020) Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleedin...
Gespeichert in:
| Veröffentlicht in: | Der Kardiologe 2021-02, Vol.15 (1), p.6-8 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | ger |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 8 |
|---|---|
| container_issue | 1 |
| container_start_page | 6 |
| container_title | Der Kardiologe |
| container_volume | 15 |
| creator | Eggebrecht, Holger |
| description | Originalpublikation Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, TICO Investigators (2020) Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: Nach 12 Monaten trat der primäre Endpunkt bei insgesamt 3,9 % der Patienten der Monogruppe auf vs. 5,9 % in der DAPT-Gruppe (Hazard Ratio 0,66, p = 0,01). Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L Bhatt, Paul Dendale, Maria Dorobantu, Thor Edvardsen, Thierry Folliguet, Chris P Gale, Martine Gilard, Alexander Jobs, Peter Jüni, Ekaterini Lambrinou, Basil S Lewis, Julinda Mehilli, Emanuele Meliga, Béla Merkely, Christian Mueller, Marco Roffi, Frans H Rutten, Dirk Sibbing, George C M Siontis, ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. |
| doi_str_mv | 10.1007/s12181-020-00427-8 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2919985485</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2919985485</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1858-3ad4d93650f69de48ba4e5dafdeb36d6420859aa750346a289deb08240421be93</originalsourceid><addsrcrecordid>eNp9kbtOwzAUhiMEEqXwAkyWmA2247gOC6oqLhVFHVpmy2lO0pTGLnZSqUy8AxuPx5PgUi4bky35-79z5D-KTik5p4T0LjxlVFJMGMGEcNbDci_qUCk4TntM7P_eqTyMjrxfECJilohO9D4dDsZ40rR5BZeoP5ngwkEFaDp3ts7sy6YBo8vSQambyho_h7puTYmMns3RvXXWaFeZBtwazBZAGVRIP7UN1D_PfmPyIEMfr29o6Bs0rWY6CJfW4QdrbDMHp1dhZNgA9ZdBZcKoNVwdRweFXno4-T670ePN9XRwh0fj2-GgP8IzKhOJY53zPI1FQgqR5sBlpjkkuS5yyGKRC86ITFKtewmJudBMBigjkvHwTzSDNO5GZzvvytnnFnyjFrYNSyy9YilNU5lwmQSK7aiZs947KNTKVbV2G0WJ2nagdh2o0IH66kDJEIp3IR9gU4L7U_-T-gRGpY4o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2919985485</pqid></control><display><type>article</type><title>TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?</title><source>ProQuest Central (Alumni Edition)</source><source>ProQuest Central UK/Ireland</source><source>ProQuest Central</source><creator>Eggebrecht, Holger</creator><creatorcontrib>Eggebrecht, Holger</creatorcontrib><description>Originalpublikation Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, TICO Investigators (2020) Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: Nach 12 Monaten trat der primäre Endpunkt bei insgesamt 3,9 % der Patienten der Monogruppe auf vs. 5,9 % in der DAPT-Gruppe (Hazard Ratio 0,66, p = 0,01). Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L Bhatt, Paul Dendale, Maria Dorobantu, Thor Edvardsen, Thierry Folliguet, Chris P Gale, Martine Gilard, Alexander Jobs, Peter Jüni, Ekaterini Lambrinou, Basil S Lewis, Julinda Mehilli, Emanuele Meliga, Béla Merkely, Christian Mueller, Marco Roffi, Frans H Rutten, Dirk Sibbing, George C M Siontis, ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.</description><identifier>ISSN: 1864-9718</identifier><identifier>EISSN: 1864-9726</identifier><identifier>EISSN: 1864-9718</identifier><identifier>DOI: 10.1007/s12181-020-00427-8</identifier><language>ger</language><publisher>Heidelberg: Springer Medizin</publisher><subject>Acute coronary syndromes ; Aspirin ; Cardiac Imaging ; Cardiology ; Critical Care Medicine ; Emergency Medicine ; Intensive ; Journal Club ; Medicine ; Medicine & Public Health ; Pneumology/Respiratory System</subject><ispartof>Der Kardiologe, 2021-02, Vol.15 (1), p.6-8</ispartof><rights>Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020</rights><rights>Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2020.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c1858-3ad4d93650f69de48ba4e5dafdeb36d6420859aa750346a289deb08240421be93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2919985485?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,21368,21369,27903,27904,33509,33723,43638,43784,64361,64365,72215</link.rule.ids></links><search><creatorcontrib>Eggebrecht, Holger</creatorcontrib><title>TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?</title><title>Der Kardiologe</title><addtitle>Kardiologe</addtitle><description>Originalpublikation Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, TICO Investigators (2020) Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: Nach 12 Monaten trat der primäre Endpunkt bei insgesamt 3,9 % der Patienten der Monogruppe auf vs. 5,9 % in der DAPT-Gruppe (Hazard Ratio 0,66, p = 0,01). Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L Bhatt, Paul Dendale, Maria Dorobantu, Thor Edvardsen, Thierry Folliguet, Chris P Gale, Martine Gilard, Alexander Jobs, Peter Jüni, Ekaterini Lambrinou, Basil S Lewis, Julinda Mehilli, Emanuele Meliga, Béla Merkely, Christian Mueller, Marco Roffi, Frans H Rutten, Dirk Sibbing, George C M Siontis, ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.</description><subject>Acute coronary syndromes</subject><subject>Aspirin</subject><subject>Cardiac Imaging</subject><subject>Cardiology</subject><subject>Critical Care Medicine</subject><subject>Emergency Medicine</subject><subject>Intensive</subject><subject>Journal Club</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Pneumology/Respiratory System</subject><issn>1864-9718</issn><issn>1864-9726</issn><issn>1864-9718</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kbtOwzAUhiMEEqXwAkyWmA2247gOC6oqLhVFHVpmy2lO0pTGLnZSqUy8AxuPx5PgUi4bky35-79z5D-KTik5p4T0LjxlVFJMGMGEcNbDci_qUCk4TntM7P_eqTyMjrxfECJilohO9D4dDsZ40rR5BZeoP5ngwkEFaDp3ts7sy6YBo8vSQambyho_h7puTYmMns3RvXXWaFeZBtwazBZAGVRIP7UN1D_PfmPyIEMfr29o6Bs0rWY6CJfW4QdrbDMHp1dhZNgA9ZdBZcKoNVwdRweFXno4-T670ePN9XRwh0fj2-GgP8IzKhOJY53zPI1FQgqR5sBlpjkkuS5yyGKRC86ITFKtewmJudBMBigjkvHwTzSDNO5GZzvvytnnFnyjFrYNSyy9YilNU5lwmQSK7aiZs947KNTKVbV2G0WJ2nagdh2o0IH66kDJEIp3IR9gU4L7U_-T-gRGpY4o</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Eggebrecht, Holger</creator><general>Springer Medizin</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20210201</creationdate><title>TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?</title><author>Eggebrecht, Holger</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1858-3ad4d93650f69de48ba4e5dafdeb36d6420859aa750346a289deb08240421be93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>ger</language><creationdate>2021</creationdate><topic>Acute coronary syndromes</topic><topic>Aspirin</topic><topic>Cardiac Imaging</topic><topic>Cardiology</topic><topic>Critical Care Medicine</topic><topic>Emergency Medicine</topic><topic>Intensive</topic><topic>Journal Club</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Pneumology/Respiratory System</topic><toplevel>online_resources</toplevel><creatorcontrib>Eggebrecht, Holger</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Der Kardiologe</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Eggebrecht, Holger</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative?</atitle><jtitle>Der Kardiologe</jtitle><stitle>Kardiologe</stitle><date>2021-02-01</date><risdate>2021</risdate><volume>15</volume><issue>1</issue><spage>6</spage><epage>8</epage><pages>6-8</pages><issn>1864-9718</issn><eissn>1864-9726</eissn><eissn>1864-9718</eissn><abstract>Originalpublikation Kim BK, Hong SJ, Cho YH, Yun KH, Kim YH, Suh Y, Cho JY, Her AY, Cho S, Jeon DW, Yoo SY, Cho DK, Hong BK, Kwon H, Ahn CM, Shin DH, Nam CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y, TICO Investigators (2020) Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: Nach 12 Monaten trat der primäre Endpunkt bei insgesamt 3,9 % der Patienten der Monogruppe auf vs. 5,9 % in der DAPT-Gruppe (Hazard Ratio 0,66, p = 0,01). Jean-Philippe Collet, Holger Thiele, Emanuele Barbato, Olivier Barthélémy, Johann Bauersachs, Deepak L Bhatt, Paul Dendale, Maria Dorobantu, Thor Edvardsen, Thierry Folliguet, Chris P Gale, Martine Gilard, Alexander Jobs, Peter Jüni, Ekaterini Lambrinou, Basil S Lewis, Julinda Mehilli, Emanuele Meliga, Béla Merkely, Christian Mueller, Marco Roffi, Frans H Rutten, Dirk Sibbing, George C M Siontis, ESC Scientific Document Group, 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.</abstract><cop>Heidelberg</cop><pub>Springer Medizin</pub><doi>10.1007/s12181-020-00427-8</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1864-9718 |
| ispartof | Der Kardiologe, 2021-02, Vol.15 (1), p.6-8 |
| issn | 1864-9718 1864-9726 1864-9718 |
| language | ger |
| recordid | cdi_proquest_journals_2919985485 |
| source | ProQuest Central (Alumni Edition); ProQuest Central UK/Ireland; ProQuest Central |
| subjects | Acute coronary syndromes Aspirin Cardiac Imaging Cardiology Critical Care Medicine Emergency Medicine Intensive Journal Club Medicine Medicine & Public Health Pneumology/Respiratory System |
| title | TICO-Studie: ASS-freie Thrombozytenaggregationshemmung nach Koronarintervention bei akutem Koronarsyndrom – Ist Ticagrelor-Monotherapie die Alternative? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T17%3A08%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TICO-Studie:%20ASS-freie%20Thrombozytenaggregationshemmung%20nach%20Koronarintervention%20bei%20akutem%20Koronarsyndrom%20%E2%80%93%20Ist%20Ticagrelor-Monotherapie%20die%20Alternative?&rft.jtitle=Der%20Kardiologe&rft.au=Eggebrecht,%20Holger&rft.date=2021-02-01&rft.volume=15&rft.issue=1&rft.spage=6&rft.epage=8&rft.pages=6-8&rft.issn=1864-9718&rft.eissn=1864-9726&rft_id=info:doi/10.1007/s12181-020-00427-8&rft_dat=%3Cproquest_cross%3E2919985485%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2919985485&rft_id=info:pmid/&rfr_iscdi=true |